Bio-Matrix signs contract with NeoCells and AdultCells
Pursuant to this contract, Bio-Matrix Scientific (BMSN) has agreed to cryogenic banking and processing of umbilical cord blood and adult peripheral blood stem cells of clients from both
Amberstone Biosciences has signed a partnership and licence agreement with Shanghai Henlius Biotech for conditionally activated T-cell engager candidates to treat solid tumours.